


Aspirin may help some breast cancer survivors, but changes in DNA may mean harm for others: Chemical changes in DNA — called methylation — in blood and breast cancer tumors may modify aspirin’s role in mortality risk

Pilot study of 5-hour molecular test accurately distinguishes malignant and benign breast tumors: Novel technology based on epigenetic alterations could shorten wait for a definitive diagnosis in resource-poor settings

Targeting old bottleneck reveals new anticancer drug strategy: Hot target SIRT2 regulates ribonucleotide reductase
